Journal of Gastroenterology and its Complications

Dr. Richard K. Gilroy is currently working as a Professor of Medicine and Medical Director of Liver Transplantation at the University of Kansas Medical Center in Kansas City, United States. He received his training at University of Queensland and Princess Alexandra Hospital in Queensland, Australia. He maintains active membership in the American Society of Transplant Surgeons, United Network for Organ Sharing, International Liver Transplant Society (ILTS), and the American Association for the Study of Liver Disease (AASLD). Among his many honors, he holds the position of United Network for Organ Sharing (UNOS) Medical Director of Liver Transplantation and sits on the US Food and Drug Administration Gastrointestinal Drug Advisory Committee. He has served as a section head on the abstract review committee for ILTS, has been a reviewer for the Mayo Clinic Proceedings, and currently serves as a reviewer for Gastrointestinal Endoscopy, American Journal of Transplantation, Liver Transplantation, and Journal of Hepatology. He has authored numerous journal articles, book chapters, and presentations. He has also been a principal investigator or sub-investigator for various studies in the areas of short bowel syndrome, liver transplantation, hepatitis C, and other liver diseases. He currently holds a research grant from the National Institutes of Health Liver Failure Studies Group and is a mentor for an AASLD Nurse Practitioner Training Grant.

His principle research focuses on developing and piloting clinical trials of innovative interventions that improve patient’s health outcomes and organ allograft utility. Treatment studies involve Hepatitis C, liver transplantation and short bowel syndrome. In addition, ongoing research endeavors emphasize economic performance and optimizing drug utilization as well as liver donation and allocation policy. The outcomes of experimental subjects in my clinical trials range from improved quality of life to sustained viral response, improved economic practice and utilization review. The goal of these studies is to provide a comprehensive multilevel analysis that might influence clinical and economic performance in a positive manner. My NIH research funding includes a grant from the Liver Failure Studies Group.